CDK4 and neoplasm: However, in the presence ofT-cells, CDK4/6 inhibitors were able to significantly reduce tumor spheroid sizeand these phenotypes were exacerbated when T-cells were added to tumors loadedwith their cognate viral antigens (Fig. 5a, Cytostatic).